Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Aoxin Q&M Dental Group Ltd. ( (SG:1D4) ) is now available.
Aoxin Q&M Dental Group Ltd. announced that its two hospitals in China have identified an excess claim of approximately RMB3.7 million in material costs under the government medical co-payment scheme for FY2024, following a self-review mandated by the National Healthcare Security Administration. This refund is expected to materially impact the company’s financials in the first half of FY2025, and shareholders are advised to trade cautiously.
More about Aoxin Q&M Dental Group Ltd.
Aoxin Q&M Dental Group Ltd., incorporated in Singapore, operates in the healthcare industry, focusing on dental services. The company manages hospitals and clinics, providing dental treatments and related services, with a market focus on leveraging government medical co-payment schemes in China.
Average Trading Volume: 111,009
Technical Sentiment Signal: Sell
Current Market Cap: S$22.51M
For a thorough assessment of 1D4 stock, go to TipRanks’ Stock Analysis page.